News Articles Tagged: Teratogenicity

Ensuring Safety and Efficacy: The Criticality of Acitretin (CAS 55079-83-9) in Pharmaceutical Formulations

Delve into the critical safety considerations and formulation challenges associated with Acitretin (CAS 55079-83-9), a vital pharmaceutical intermediate for dermatological therapies.

Navigating the Safety of Lenalidomide: Understanding Risks and Mitigation Strategies

A critical look at the safety profile of Lenalidomide, focusing on teratogenicity, blood disorders, and thromboembolic events, alongside essential risk management strategies, from NINGBO INNO PHARMCHEM CO.,LTD.